INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 30 June 2014
|
Net Assets |
£193m |
|
Net Assets per share |
355p |
|
Share price |
299p |
|
Total value of unquoted investments |
£18m |
|
Total number of portfolio companies |
90 |
Top Ten Holdings
|
Company Name |
% NAV |
|
Gilead |
8.4 |
|
Celgene |
7.6 |
|
Alexion |
7.4 |
|
Biogen |
7.0 |
|
Amgen |
5.6 |
|
Vertex |
5.2 |
|
Illumina |
4.2 |
|
Biomarin |
3.6 |
|
Shire |
3.3 |
|
Mylan |
3.2 |
|
|
----------- |
|
Total |
55.5 |
|
Portfolio Profitability |
% NAV |
|
Profitable |
59 |
|
Turning Profitable 2015 |
11 |
|
Unprofitable |
30 |
|
|
----------- |
|
Total |
100 |
|
Geographical Allocation |
% NAV |
|
United States & Canada |
88 |
|
Europe & UK |
12 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted Allocation |
% NAV |
|
Quoted |
92 |
|
Unquoted |
8 |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
21 JULY 2014